Previous reports have shown that various steps in the influenza A virus life cycle are impaired in cells expressing the antiapoptotic protein Bcl-2 (Bcl-2؉ cells). We demonstrated a direct link between Bcl-2 and the reduced nuclear export of viral ribonucleoprotein (vRNP) complexes in these cells. However, despite its negative impact on viral replication, Bcl-2 did not prevent host cells from undergoing virally triggered apoptosis. The protein's reduced antiapoptotic capacity was related to phosphorylation of its threonine 56 and serine 87 residues by virally activated p38MAPK. In infected Bcl-2 ؉ cells, activated p38MAPK was found predominantly in the cytoplasm, colocalized with Bcl-2, and both Bcl-2 phosphorylation and virally induced apoptosis were diminished by specific inhibition of p38MAPK activity. In contrast, in Bcl-2-negative (Bcl-2 ؊ ) cells, which are fully permissive to viral infection, p38MAPK activity was predominantly nuclear, and its inhibition decreased vRNP traffic, phosphorylation of viral nucleoprotein, and virus titers in cell supernatants, suggesting that this kinase also contributes to the regulation of vRNP export and viral replication. This could explain why in Bcl-2 ؉ cells, where p38MAPK is active in the cytoplasm, phosphorylating Bcl-2, influenza viral replication is substantially reduced, whereas apoptosis proceeds at rates similar to those observed in Bcl-2 ؊ cells. Our findings suggest that the impact of p38MAPK on the influenza virus life cycle and the apoptotic response of host cells to infection depends on whether or not the cells express Bcl-2, highlighting the possibility that the pathological effects of the virus are partly determined by the cell type it targets.The influenza A virus, a widespread human pathogen, is characterized by a segmented negative strand RNA genome that encodes 11 viral proteins. Within the envelope, the eight viral RNA segments, associated with the nucleoprotein (NP) 3 and the polymerase complex, form helical ribonucleoprotein capsids (vRNP S ). After infection, the vRNP S are transported to the host cell nucleus, where they undergo transcription and replication. In the late phase of replication, newly formed RNP S are transferred from the nucleus to the cytoplasm and packaged into progeny virions (1-3). Such an essential step in the life cycle of the virus is known to be regulated in part by viral and host cell factors (4 -9), including the expression of Bcl-2, which varies widely from one cell type to another (6, 10, 11). This transmembrane protein is well known for its ability to prevent the apoptotic cell death provoked by a variety of stimuli (12), a property that is markedly diminished when Bcl-2 undergoes phosphorylation by several different cellular kinases (13-16). Several lines of evidence indicate that host cell expression of Bcl-2 is associated with impaired replication of the influenza A virus (6, 17) and significant suppression of vRNP translocation into the cytoplasm (6). We have suggested that the latter effect might be related to inte...